<DOC>
	<DOCNO>NCT02209805</DOCNO>
	<brief_summary>Study assess safety pharmacokinetics BIRB 796 BS tablet administer multiple daily dose various dose level .</brief_summary>
	<brief_title>Safety Pharmacokinetics BIRB 796 BS Tablets Administered Healthy Human Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male subject determine result screen Signed write informed consent accordance Good Clinical Practice local legislation Age &gt; = 18 &lt; = 45 year Broca &gt; = 20 % &lt; = + 20 % Able communicate well investigator comply study requirement &gt; 10 elimination half live present since last use investigational drug investigational drug Laboratory value within clinically relevant reference range Any finding medical examination ( include blood pressure , pulse rate , temperature , EKG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator History vasculitis ( past history fever , malaise , myalgia , rash , etc . ) Intake drug long halflife ( &gt; 24 hour ) ( &lt; 1 month prior administration trial ) Use drug , might influence result trial , ( &lt; 10 day prior administration trial ) Participation another trial investigational drug ( &lt; 1 month prior administration trial ) Smoker Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Use methylxanthinecontaining drink food ( coffee , tea , cola , energy drink , chocolate , etc . ) &lt; one week prior administration study drug Blood donation loss &gt; 400 mL ( &lt; 1 month prior administration trial ) Excessive physical activity ( &lt; 5 day prior administration trial ) Following specific laboratory finding : total white blood cell &gt; = 10 x 109/L , CReactive Protein &gt; = 4.5 mg/L , gammaglutamyltransferase &gt; = 25 U/L , aspartate transaminase &gt; = 16 U/L , alanine transaminase &gt; = 20 U/L erythrocyte &gt; 15 mg/dl protein urine dipstick Any EKG value outside reference range clinical relevance include , limited QTcB &gt; 480 m , PR interval &gt; 240 m , QRS interval &gt; 110 ms History familial bleeding disorder Inability comply dietary regimen study centre Inability comply investigator 's instruction</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>